IN2011KN04192A - - Google Patents

Info

Publication number
IN2011KN04192A
IN2011KN04192A IN4192KON2011A IN2011KN04192A IN 2011KN04192 A IN2011KN04192 A IN 2011KN04192A IN 4192KON2011 A IN4192KON2011 A IN 4192KON2011A IN 2011KN04192 A IN2011KN04192 A IN 2011KN04192A
Authority
IN
India
Prior art keywords
methylphenyl
preparation
thiazolo
cyclopropyl
fluoro
Prior art date
Application number
Inventor
Zsolt Párkányi
János Fazekas
Péter Miskolczi
Annamária Molnár
Béla Ágai
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of IN2011KN04192A publication Critical patent/IN2011KN04192A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/02—Thiocyanates
    • C07C331/04—Thiocyanates having sulfur atoms of thiocyanate groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F216/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical
    • C08F216/12—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical by an ether radical
    • C08F216/14—Monomers containing only one unsaturated aliphatic radical
    • C08F216/1466—Monomers containing sulfur
    • C08F216/1483—Monomers containing sulfur and nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

The subject of the present invention is a novel process for the preparation of the [4-(2-chloro-4-methoxy-5-methylphenyl)-5-methyl-thiazolo-2-yl]-[2-cyclopropyl- 1-(3-fluoro-4-methylphenyl)-ethyl]-amine of formula (I) and the new intermediates of the preparation process.
IN4192KON2011 2009-04-30 2010-04-26 IN2011KN04192A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0900267A HUP0900267A2 (en) 2009-04-30 2009-04-30 Process for preparing of thiazole amines and intermediates thereof
PCT/HU2010/000047 WO2010125414A1 (en) 2009-04-30 2010-04-26 Process for the preparation of [4-(2-chloro-4-methoxy-5-methylphenyl)-5-methyl-thiazolo-2-yl]-[2-cyclopropyl-1-(3-fluoro-4-methylphenyl)-ethyl]-amine

Publications (1)

Publication Number Publication Date
IN2011KN04192A true IN2011KN04192A (en) 2015-10-02

Family

ID=89988941

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4192KON2011 IN2011KN04192A (en) 2009-04-30 2010-04-26

Country Status (19)

Country Link
US (1) US8314249B2 (en)
EP (1) EP2424848B1 (en)
JP (1) JP5608221B2 (en)
KR (1) KR20120014005A (en)
CN (1) CN102414185B (en)
AR (1) AR076478A1 (en)
AU (1) AU2010243362B2 (en)
BR (1) BRPI1014627A2 (en)
CA (1) CA2760384A1 (en)
HU (1) HUP0900267A2 (en)
IL (1) IL216017A0 (en)
IN (1) IN2011KN04192A (en)
MX (1) MX2011011530A (en)
MY (1) MY152269A (en)
RU (1) RU2523793C2 (en)
SG (1) SG175829A1 (en)
TW (1) TWI461413B (en)
UY (1) UY32594A (en)
WO (1) WO2010125414A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8943551B2 (en) * 2008-08-14 2015-01-27 Microsoft Corporation Cloud-based device information storage
HUP0900267A2 (en) 2009-04-30 2011-03-28 Sanofi Aventis Process for preparing of thiazole amines and intermediates thereof
WO2015112642A1 (en) 2014-01-21 2015-07-30 Neurocrine Biosciences, Inc. Crf1 receptor antagonists for the treatment of congenital adrenal hyperplasia
US10207974B1 (en) 2017-12-05 2019-02-19 Chevron Phillips Chemical Company Lp Synthesis of gamma dicarbonyl and pyrrole compounds
SG11202105930QA (en) 2018-12-07 2021-07-29 Neurocrine Biosciences Inc Crf1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasia
CN114502162A (en) * 2019-09-27 2022-05-13 纽罗克里生物科学有限公司 CRF receptor antagonists and methods of use
KR20230038458A (en) 2020-06-10 2023-03-20 뉴로크린 바이오사이언시즈 인코퍼레이티드 CRF1 receptor antagonists for the treatment of congenital adrenal hyperplasia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB823251A (en) 1955-07-02 1959-11-11 Thomae Gmbh Dr K Improvements in or relating to preparations containing benzoxathiol derivatives for the care of hair and skin
US3222248A (en) * 1961-12-12 1965-12-07 Stauffer Chemical Co Method of controlling microorganisms by means of organic thiocyanates
US3433803A (en) 1966-12-01 1969-03-18 Olin Mathieson Substituted imino-1,3-oxathiols and their preparation
IS1688B (en) 1991-10-30 1998-04-20 Ab Astra A novel process for the preparation of 4-methyl-5- (2-chloroethyl) thiazole and its analogues and novel intermediates in the preparation of the compounds
JPH1036360A (en) 1996-02-21 1998-02-10 Kuraray Co Ltd Production of 2-chloro-5-chloromethyl-1,3-thiazole
FR2796380B3 (en) * 1999-07-15 2001-08-17 Sanofi Synthelabo NOVEL AMINOTHIAZOL DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HUP0900267A2 (en) 2009-04-30 2011-03-28 Sanofi Aventis Process for preparing of thiazole amines and intermediates thereof

Also Published As

Publication number Publication date
TWI461413B (en) 2014-11-21
HU0900267D0 (en) 2009-07-28
CN102414185B (en) 2014-02-26
WO2010125414A1 (en) 2010-11-04
MX2011011530A (en) 2011-11-18
TW201105640A (en) 2011-02-16
BRPI1014627A2 (en) 2015-08-25
JP2012525368A (en) 2012-10-22
AU2010243362B2 (en) 2015-07-30
JP5608221B2 (en) 2014-10-15
US8314249B2 (en) 2012-11-20
WO2010125414A8 (en) 2011-04-07
KR20120014005A (en) 2012-02-15
AR076478A1 (en) 2011-06-15
UY32594A (en) 2010-11-30
US20120083608A1 (en) 2012-04-05
AU2010243362A1 (en) 2011-11-17
RU2011148584A (en) 2013-06-10
CN102414185A (en) 2012-04-11
HUP0900267A2 (en) 2011-03-28
EP2424848A1 (en) 2012-03-07
CA2760384A1 (en) 2010-11-04
IL216017A0 (en) 2012-01-31
SG175829A1 (en) 2011-12-29
EP2424848B1 (en) 2013-03-13
RU2523793C2 (en) 2014-07-27
MY152269A (en) 2014-09-15

Similar Documents

Publication Publication Date Title
MY152269A (en) Process for the preparation of [4-(2-chloro-4-methoxy-5-methylphenyl)-5-methyl-thiazolo-2-yl]-[2-cycloropyl-1-(3-fluoro-4-methylphenyl)-ethyl]-amine
TN2011000673A1 (en) Bace inhibitors
GEP201706745B (en) Forms of rifaximin and usage thereof
GEP20146124B (en) Novel ccr2 receptor antagonists and usage thereof
ZA201108644B (en) A novel formulation of metaxalone
EP2462115A4 (en) Enzymatic transamination of cyclopamine analogs
HK1169396A1 (en) Improved process for the preparation of ambrisentan and novel intermediates thereof
MX2013002851A (en) Inhibitors of notum pectinacetylesterase and methods of their use.
TNSN08244A1 (en) Process for the preparation of ferri-succinylcasein
IN2012DN00369A (en)
PL2462121T3 (en) Derivatives of 2h pyridazin-3-ones, their preparation and their use as scd-1 inhibitors
IN2014MN00850A (en)
MX2012000267A (en) Pyrazole derivatives, preparation thereof, and therapeutic use thereof.
NZ605804A (en) New aminopyrazoloquinazolines
IN2012DN01929A (en)
JO2812B1 (en) New Process for obtaining the crystalline form V of agomelatine
MY160625A (en) Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation
MX339513B (en) Sec-hydroxycyclohexyl derivatives as hsl inhibitors for the treatment diabetes.
MX337610B (en) Processes for the preparation of (r)-2-acetamido-n-benzyl- 3-methoxypropionamide and intermediates thereof.
NZ606574A (en) Novel synthesis for thiazolidinedione compounds
IL213770A0 (en) Novel use of fibrates
EP2471788A4 (en) Novel compound amycolose derivative, and production process and use of same
MX352295B (en) Substituted phenyl compounds.
EP2379502A4 (en) Novel forms of eperisone
WO2009078036A3 (en) Process and intermediate of letrozole